Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Liquidia Corp (NQ: LQDA )

7.250 +0.150 (+2.11%)
Streaming Delayed Price Updated: 9:55 AM EDT, Mar 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 30,139
Open 7.220
Bid (Size) 7.250 (2)
Ask (Size) 7.280 (4)
Prev. Close 7.100
Today's Range 7.170 - 7.300
52wk Range 3.260 - 8.790
Shares Outstanding 64,688,314
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Where Liquidia Stands With Analysts
 
Via Benzinga
Needham Maintains Buy Rating for Liquidia: Here's What You Need To Know
 
Via Benzinga

Performance

YTD
+19.05%
+19.05%
1 Month
-2.68%
-2.68%
3 Month
+23.72%
+23.72%
6 Month
+26.97%
+26.97%
1 Year
+4.47%
+4.47%

More News

Read More
NVIDIA To Rally Around 19%? Here Are 10 Other Analyst Forecasts For Friday
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Liquidia Corporation Reports Full Year 2022 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via Globe NewsWire
Liquidia Technologies's Earnings: A Preview
Via Benzinga
4 Analysts Have This to Say About Liquidia
Via Benzinga
Liquidia Corporation to Report Full Year 2022 Financial Results on Thursday, March 16, 2023
From Liquidia Corporation
Via Globe NewsWire
Patent Trial and Appeal Board (PTAB) Reaffirms Decision to Invalidate All Claims of United Therapeutics (UTHR) Patent No. 10,716,793 (‘793 Patent)
From Liquidia Corporation
Via Globe NewsWire
Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Liquidia Corporation
Via Globe NewsWire
Liquidia Enters Into a Revenue Interest Financing Agreement With HealthCare Royalty for Up to $100 Million
From Liquidia Corporation
Via Globe NewsWire
Liquidia Announces Collaboration to Develop a New Infusion Pump for Subcutaneous Delivery of Treprostinil Injection to Treat Pulmonary Arterial Hypertension (PAH)
From Liquidia Corporation
Via Globe NewsWire
Liquidia Reports Third Quarter 2022 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via Globe NewsWire
Earnings Outlook For Liquidia Technologies
Via Benzinga
Liquidia to Report Third Quarter 2022 Financial Results on November 8, 2022
From Liquidia Corporation
Via Globe NewsWire
Precedential Opinion Panel Denies United Therapeutics’ Request for Review of ‘793 Inter Partes Review Decision
From Liquidia Corporation
Via Globe NewsWire
Liquidia Announces Presentations at the CHEST 2022 Annual Meeting
From Liquidia Corporation
Via Globe NewsWire
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
Via InvestorPlace
7 Momentum Stocks to Buy Now for Extraordinary Gains
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Lululemon Athletica Is Trading Higher By 11%, Here Are 36 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2022
Via Benzinga
Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday
Via Benzinga
Why Okta Is Trading Lower By Over 32%, Here Are 58 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.